FDS
BEAT

First Dallas Securities’s BioTelemetry, Inc. BEAT Stock Holding History

First Dallas Securities’s Portfolio BEAT Stock Details BEAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-4,450
Closed -$133K – 146
2017
Q4 		$133K Buy
+4,450
New +$129K 0.08% 124

Other funds holding BEAT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

First Dallas Securities's BEAT Position: Q1 2018 in Review

First Dallas Securities sold out of BioTelemetry, Inc. (BEAT) in Q1 2018, closing a stake of 4,450 shares — an estimated $133K sold.

First Dallas Securities first reported a position in BEAT in Q4 2017 and held it in 1 quarter. The position peaked at $133K in Q4 2017. 202 funds tracked by Wall St. Rank hold BEAT as of Q1 2018.

  • First Dallas Securities reported no remaining BioTelemetry, Inc. position as of Q1 2018 after selling out during the quarter.
  • First Dallas Securities sold 4,450 BioTelemetry, Inc. shares in Q1 2018, an estimated $133K.
  • First Dallas Securities first reported a position in BioTelemetry, Inc. in Q4 2017 and held it in 1 quarter.
  • First Dallas Securities's BioTelemetry, Inc. position peaked at $133K in Q4 2017.
  • 202 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2018.

Based on First Dallas Securities's 13F filing for Q1 2018, filed 4 May 2018.